💡 Did you know?
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
History
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
Artemis Medicare Services Limited is an India-based company. The Company manages and operates a multi-specialty hospital. It specializes in a range of advanced medical and surgical interventions, a mix of inpatient and outpatient services. It offers treatment facilities for…
Weekly engine runs — movement reflects the numbers, not analyst opinion.
A decent, fast-growing business, reasonably priced — but flagged on governance.
Artemis Med Service is scored on the pharma / healthcare framework. It keeps a slim 9.3% of every rupee of sales as net profit. Those profits are backed by real cash — operating cash flow runs 1.27× reported profit. Free cash flow is worth about 0.9% of its market value.
Over the last 3 years revenue compounded at 14%/yr and profit at 40%/yr. Book value itself has compounded 32%/yr — the hallmark of a genuine compounder. Return on equity is a modest 11.6%. In the latest quarter profit fell 1% versus the prior quarter.
At 47× earnings, the stock sits at the 38th percentile of its own 3.6-year range — the middle of where it has historically traded. Today's price already implies ~19%/yr earnings growth sustained for a decade — a demanding bar. The forensic screen raises a red flag: Share count up 20% over 4 years — heavy equity dilution.
A plain-English restatement of the figures on this page — rules-based, for education and research context, not investment advice or a recommendation.
| Ratio | Company | Sector | Read |
|---|---|---|---|
| P/E | 42.16 | 75.46 | better |
| P/B | 5.27 | 3.5 | worse |
| EV/EBITDA | 20.7 | 19.83 | worse |
| ROE | 11.59 | — | — |
| ROCE | 13.75 | 10.78 | better |
| ROA | 7.2 | 3.84 | better |
| Quick Ratio | 1.68 | — | — |
| Peer | P/E | P/B | ROE |
|---|---|---|---|
| Apollo Hospitals | 52.0 | 11.4 | 21.1% |
| Max Healthcare | 65.9 | 8.0 | 12.2% |
| Manipal Health Enterprises | 93.9 | 5.2 | 10.6% |
Revenue has grown every year across all 4 financial years shown. 14% CAGR over 3 years — steady double-digit compounder. Growth is accelerating — latest year outpaced the prior year's rate.
Net profit has risen every year — the hallmark of a compounder. Profit is growing faster than revenue (40% vs 14%) — margin expansion is at work.
Operating margin has expanded from 7% to 13% — the business is keeping more of each rupee earned.
ROE at 11% — modest; the capital isn't working hard. Low variance across years — a predictable business that earns steadily on its equity base.
EPS has grown every year — each share earns more than the last, consistently. Profit grew faster than EPS (40% vs 31%) — share dilution is eroding per-share value. 31% EPS CAGR — this is the rate at which each share's claim on earnings is compounding.
Operating cash flow has been positive every year — the business generates real cash, not just accounting profit. Cash conversion at 1.3× PAT — earnings are well-backed by cash; strong accrual quality. Heavy investing spend every year, but operations generate enough to cover it — the business self-funds its growth.
When operating cash keeps pace with reported profit, earnings are cash-backed; a persistent shortfall is a quality flag.
Revenue rose 9% sequentially — momentum is building.
How today's P/E compares to the stock's own historical range. Dashed line = the 3.6y median.
Promoter holding at 58.4% — majority control intact.
Produced by a rules-based engine over licensed exchange fundamentals — every sentence above is derived from the numbers shown, no analyst or AI opinion involved. Education and research context, not investment advice. We are not SEBI-registered as an Investment Adviser or Research Analyst.